Stock data

杏一 (4175)

杏一 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$662.61M, up 0.3% from a year earlier. EPS over the last four quarters totals NT$3.79.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 杏一 in Insightr